ArticleAdvances in therapy2022

Risk of Severe COVID-19 Outcomes Among Patients with Immune-Mediated Inflammatory Diseases or Malignancies: A Retrospective Analysis of Real-World Data in the United States.

Xiaomeng Yue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.